Normally, statistics published by the media conglomerate Bloomberg and information published by the media in general, tend to serve as a guide for stockbrokers looking to invest rather than the everyday citizen of any country in the world. 

Followed by Argentina and Peru, Bloomberg has rated Mexico as the most dangerous country to live in during the global COVID-19 pandemic. The determination is based on the "lowest resilience rate," which means higher mortality among fewer positive cases of the virus. In the end, it is a question of resources to access a coronavirus test. For example, the total number of deaths in Peru is higher, but so is its ability to test the population. 

The first in terms of safety is New Zealand, where the government initially invested in testing, contact tracing, and enforced a strict quarantine. It demonstrated that the pandemic can be mitigated if not stopped by an intelligent choice in optimizing state resources. 

Behind Brazil, which has zero policy on the virus, are Chile, Spain, and Colombia. The little budgetary margin of these countries for tracking must be considered, as many asked for volunteers in the fight. The high cost of certain medicines for those already affected also had an effect on a country's ability to respond. Trying to interpret the different values in the study can be deduced that undetected cases are still the global norm.

Meanwhile, Mexico continues to quake economically because of deaths, business closures, loss of purchasing power, unemployment, and the increasing rates of poverty. In the same vein, the well-known technology chain store, Best Buy, announced it was withdrawing from the country because business has become unviable. Forty-one branches closed, costing hundreds of jobs. 

To counteract the effects on the stock market of Bloomberg's announcement, the Mexican Secretary of Foreign Affairs, Marcelo Ebrard, jumped one social media to assure that the Pzifier vaccine would arrive to the country in December of this year and there would be plans with other vaccines (AstraZeneca/Oxford, Moderna) in development. Citizens took to social media too and expressed their cynicism about the government's ability to deliver on such a promise.